Comment · Sun, January 10, 2016
Deoxygedunin is a small-molecule TrkB agonist with improved potency and duration relative to 7,8-DHF
What they were answering
Direct reply to the original post in this thread.
u/MisterYouAreSoDumb
The water solubility issue is a big one. People are going to want to take it orally, or at least sublingually. Injecting it will make it much less approachable. There are other more bioavailable versions of 7,8-DHF that we are working on instead.